Roberto Velarde joins Santiago, Chile-based Inder, the investment group that is run by the members of the Del Rio Family. The group focuses on deals ranging in size from $30 million to $150 million. Velarde is a veteran of JP Morgan Partners.
Nov 28 (Reuters) – Private equity firm Nordic Capital has appointed Carnegie and SEB Enskilda as advisors for the sale or public listing of Swedish industrial packaging firm Nefab, sources familiar with the matter said on Monday. One of the sources said the deal could be worth between 2 billion crowns ($286 million) and 3 […]
The American economy is a mess. Growth has been stuck at a tortoise-like pace for years. The unemployment rate continues to hover at nine percent or higher. And faltering research and development threatens not only innovation, but our future. The good news is there’s a fix for this: The U.S. government simply needs to invest […]
(Reuters) – Private equity group KKR & Co is about to secure a deal to buy Capital Safety Group (CSG), a British manufacturer of safety equipment to protect against falls, for about $1.1 billion, a source familiar with the matter said on Monday. An agreement with the target company’s owners, Arle Capital Partners — the […]
Boston-based buyout shop Riverside Partners is taking a majority stake in ITC Global, a provider of satellite communications services to mining, energy and maritime businesses operating in remote environments. Terms of the deal were not released.
Private equity group KKR & Co. is about to secure a deal to buy Capital Safety Group, a British manufacturer of safety equipment to protect against falls, for about $1.1 billion, Reuters reported Monday. Capital Safety Group is currently owned by Arle Capital Partners.
Billionaire investor Carl Icahn has offered $15 a share, or $1.73 billion, for Texas-based Commercial Metals Co. The deal would combine the metals recycler with Icahn’s PSC Metals Inc., Reuters reported.
The Royal Bank of Scotland has collected final bids for its RBS Aviation Capital aircraft leasing business and hopes to select a preferred bidder early next year, Reuters wrote Monday. China Development Bank, Wells Fargo, Sumitomo Mitsui Financial Group and a Macquarie-led consortium are in the running for the business, which RBS is selling as part of a broader strategy to divest non-core assets.
Rib-X Pharmaceuticals Inc., a New Haven, Conn.-based pharmaceutical developer, has filed plans for an initial public offering to raise up to $80 million. The company had previously raised capital from investors including Warburg Pincus, ABS Ventures, Axiom Ventures, EuclidSR Partners, MedImmune Ventures, Oxford Bioscience Partners and S.R. One. Deutsche Bank Securities will act as the sole book-running manager for the offering. William Blair & Company, Lazard Capital Markets and Needham & Co. will act as co-managers.
New China Life Insurance Co Ltd has received commitments from four cornerstone investors for $780 million worth of shares in the Hong Kong tranche of its initial public offering, IFR reported on Monday, citing two sources with direct knowledge of the deal, Reuters reports. Among the investors is South Korean private equity firm MBK Partners […]